|Indian Drugs & Pharmaceuticals Ltd.|
|PO No 3816, New Delhi 110049.|
Indian Drugs & Pharmaceuticals Ltd.
All Brands From Indian Drugs & Pharmaceuticals Ltd.
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor